港股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

复宏汉霖

84.450

+1.4001.69%

成交量：79.82万

成交额：6,680.07万

市值：458.56亿

市盈率：48.62

高：84.450

开：82.400

低：81.300

收：83.050

52周最高：92.000

52周最低：32.750

股本：5.43亿

香港流通股本：3.46亿

量比：0.72

换手率：0.23%

股息：- -

股息率：- -

每股收益(LYR):1.737

净资产收益率：23.72%

总资产收益率：4.45%

市净率：10.06

市盈率(LYR):48.62

市销率: 5.98

数据加载中...

总览公司新闻资讯公告

关键研究启航，复星医药子公司复宏汉霖PD-L1 ADC HLX43在美国启动sqNSCLC II/III期临床试验

复星医药官微

行业动态 | 全球研发 | 复星医药子公司复宏汉霖下一代TCE四特异性抗体HLX3901获国家药监局IND许可

每日卖空追踪 | 复宏汉霖 03月11日卖空量成交8700股，卖空比例为4.96%

复宏汉霖PD-L1 ADC启动全球II/III期关键研究

医药魔方Info

同一日，康宁杰瑞、复宏汉霖等多家药企创新药迎来临床新进展

港股异动 | 复宏汉霖(02696)再涨超8% B7-H3唾液酸酶融合蛋白HLX316临床研究申请获批

复宏汉霖盘中异动股价大涨5.69%

潜在FIC，复宏汉霖B7-H3唾液酸酶融合蛋白HLX316临床研究申请中国获批

复星医药子公司复宏汉霖下一代TCE四特异性抗体HLX3901获国家药监局IND许可

复星医药官微

复宏汉霖(02696)：HLX3901注射液(DLL3xDLL3xCD3xCD28四特异性抗体)在晚期/转移性实体瘤患者中的临床试验申请获国家药品监督管理局批准

每日卖空追踪 | 复宏汉霖 03月09日卖空量成交14.8万股，卖空比例为7.46%

复宏汉霖盘中异动早盘大幅跳水5.07%

《股市简讯》中国复宏汉霖一度涨6.3%，国家药监局批准其抗癌药临床试验

创新药板块强势三生制药(01530)涨9.83% 机构指业绩兑现有望催化板块行情

港股异动 | 复宏汉霖(02696)涨超5% 自研KAT6A/B小分子抑制剂HLX97获国家药监局IND许可

全球尚无同类产品：复宏汉霖HLX97临床试验获批靶向晚期/转移性实体瘤

复宏汉霖HLX97（Kat6a/B小分子抑制剂）临床试验申请获国家药监局批准

复宏汉霖党委书记、董事会秘书王燕：优化生物医药政策环境激发产业内生动力

每日经济新闻

复宏汉霖（02696）2月股份变动月报表：H股转增182,645,856股

复宏汉霖潜在 best-in-class 小分子新药首次获批临床

丁香园 Insight 数据库

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/02696/news?page=3"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02696","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02696\",,,,,undefined,":{"symbol":"02696","market":"HK","secType":"STK","nameCN":"复宏汉霖","latestPrice":84.45,"timestamp":1776413294007,"preClose":83.05,"halted":0,"volume":798182,"delay":0,"changeRate":0.016857314870559973,"floatShares":346074397,"shares":543000000,"eps":1.7368511998306788,"marketStatus":"休市中","change":1.4,"latestTime":"04-17 16:08:14","open":82.4,"high":84.45,"low":81.3,"amount":66800669,"amplitude":0.037929,"askPrice":84.45,"askSize":3400,"bidPrice":84,"bidSize":300,"shortable":3,"etf":0,"ttmEps":1.7372906998620348,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1776648600000},"marketStatusCode":7,"adr":0,"listingDate":1569340800000,"exchange":"SEHK","adjPreClose":83.05,"openAndCloseTimeList":[[1776389400000,1776398400000],[1776402000000,1776412800000]],"volumeRatio":0.720540581952125,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02696\",,,,,undefined,":{"symbol":"02696","floatShares":346074397,"roa":"4.45%","roe":"23.72%","lyrEps":1.736851,"volumeRatio":0.720540581952125,"shares":543000000,"dividePrice":0,"high":84.45,"amplitude":0.037929,"preClose":83.05,"low":81.3,"week52Low":32.75,"pbRate":"10.06","psRate":"5.98","week52High":92,"institutionHeld":0,"latestPrice":84.45,"committee":-0.837838,"eps":1.7368511998306788,"divideRate":0,"volume":798182,"delay":0,"ttmEps":1.7372906998620348,"open":82.4,"prevYearClose":57.05,"prevWeekClose":83.35,"prevMonthClose":69.75,"prevQuarterClose":69.75,"fiveDayClose":83.35,"twentyDayClose":66.15,"sixtyDayClose":67.4},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02696\",params:#limit:5,,,undefined,":[{"market":"HK","date":"2026-03-20","symbol":"02696","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1773936000000,"reportTimeType":"post","actualEps":null},{"date":"2025-08-25","symbol":"02696","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756085400000,"name":null,"time":"","dateTimestamp":1756051200000,"actualEps":null},{"date":"2025-03-24","symbol":"02696","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742779800000,"name":null,"time":"盘后","dateTimestamp":1742745600000,"actualEps":null},{"market":"HK","date":"2025-02-10","symbol":"02696","reason":null,"defaultRemindTime":1739151000000,"announcedDate":"2024-12-23","type":"delisting","dateTimestamp":1739116800000},{"market":"HK","date":"2024-08-26","symbol":"02696","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1724601600000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02696\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02696\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.2,"buy":0.8,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8,"analysts":5,"updateTime":1761840000000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02696\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02696","date":"2026-04-16","current":48.610172,"percent":0.908869,"low":-39.586964,"twenty":-10.951311,"median":-6.649691,"eighty":36.992005,"high":139.007258,"avg":13.731968,"sd":36.851143,"marketCap":45137247541},"quantilePoints":[{"date":"2021-04-23","current":-19.645162,"twenty":-19.476333,"median":-18.226089,"eighty":-17.316751,"marketCap":23315929193},{"date":"2021-04-30","current":-19.040057,"twenty":-19.648003,"median":-18.297927,"eighty":-17.448129,"marketCap":22690910112},{"date":"2021-05-07","current":-17.965945,"twenty":-19.565472,"median":-18.363013,"eighty":-17.482435,"marketCap":21549570921},{"date":"2021-05-14","current":-18.113671,"twenty":-19.510182,"median":-18.274791,"eighty":-17.482435,"marketCap":21712619377},{"date":"2021-05-21","current":-18.357986,"twenty":-19.487135,"median":-18.274791,"eighty":-17.516465,"marketCap":22011541546},{"date":"2021-05-28","current":-18.986811,"twenty":-19.432718,"median":-18.278327,"eighty":-17.567256,"marketCap":22989832281},{"date":"2021-06-04","current":-18.085054,"twenty":-19.394728,"median":-18.274791,"eighty":-17.569054,"marketCap":21794143605},{"date":"2021-06-11","current":-17.838307,"twenty":-19.380637,"median":-18.278327,"eighty":-17.596682,"marketCap":21495221436},{"date":"2021-06-18","current":-16.028857,"twenty":-19.316527,"median":-18.226089,"eighty":-17.499595,"marketCap":19158193568},{"date":"2021-06-25","current":-17.449469,"twenty":-19.090843,"median":-18.120466,"eighty":-17.407752,"marketCap":20843027612},{"date":"2021-07-02","current":-17.434433,"twenty":-19.054867,"median":-18.089655,"eighty":-17.397323,"marketCap":20788678127},{"date":"2021-07-09","current":-16.265645,"twenty":-19.040057,"median":-18.074879,"eighty":-17.195892,"marketCap":19375591509},{"date":"2021-07-16","current":-15.969405,"twenty":-19.032975,"median":-18.040488,"eighty":-17.122755,"marketCap":19022319855},{"date":"2021-07-23","current":-15.856864,"twenty":-19.023636,"median":-18.026565,"eighty":-17.079749,"marketCap":18886446141},{"date":"2021-07-30","current":-14.666803,"twenty":-18.986811,"median":-17.998882,"eighty":-16.849549,"marketCap":17527709009},{"date":"2021-08-06","current":-14.588335,"twenty":-18.965589,"median":-17.945733,"eighty":-16.750714,"marketCap":17391835296},{"date":"2021-08-13","current":-14.52296,"twenty":-18.953047,"median":-17.911145,"eighty":-16.470265,"marketCap":17337485810},{"date":"2021-08-20","current":-13.520478,"twenty":-18.945494,"median":-17.88088,"eighty":-16.251298,"marketCap":15217855884},{"date":"2021-08-27","current":-12.980395,"twenty":-18.88847,"median":-17.842996,"eighty":-16.122732,"marketCap":14674361031},{"date":"2021-09-03","current":-12.734842,"twenty":-18.882406,"median":-17.809029,"eighty":-15.859736,"marketCap":14402613604},{"date":"2021-09-10","current":-13.373232,"twenty":-18.846812,"median":-17.803134,"eighty":-15.761703,"marketCap":15163506398},{"date":"2021-09-17","current":-12.138916,"twenty":-18.846135,"median":-17.730953,"eighty":-15.089723,"marketCap":13723245038},{"date":"2021-09-24","current":-11.82096,"twenty":-18.810911,"median":-17.571343,"eighty":-14.867281,"marketCap":13369973383},{"date":"2021-09-30","current":-11.757587,"twenty":-18.785539,"median":-17.567074,"eighty":-14.603567,"marketCap":13342798641},{"date":"2021-10-08","current":-10.872073,"twenty":-18.769634,"median":-17.476946,"eighty":-14.333569,"marketCap":12337333163},{"date":"2021-10-15","current":-12.085096,"twenty":-18.725638,"median":-17.441951,"eighty":-13.86094,"marketCap":13723245038},{"date":"2021-10-22","current":-11.832626,"twenty":-18.639753,"median":-17.36388,"eighty":-13.648942,"marketCap":13533021839},{"date":"2021-10-29","current":-12.004873,"twenty":-18.601961,"median":-17.24697,"eighty":-13.384811,"marketCap":13696070295},{"date":"2021-11-05","current":-11.842443,"twenty":-18.587887,"median":-17.177529,"eighty":-13.069878,"marketCap":13533021839},{"date":"2021-11-12","current":-13.238443,"twenty":-18.539285,"median":-17.121354,"eighty":-12.950721,"marketCap":15190681141},{"date":"2021-11-19","current":-13.755236,"twenty":-18.493787,"median":-17.09849,"eighty":-12.989283,"marketCap":15761350737},{"date":"2021-11-26","current":-15.860878,"twenty":-18.471737,"median":-16.981974,"eighty":-13.021471,"marketCap":18179902832},{"date":"2021-12-03","current":-12.565895,"twenty":-18.441097,"median":-16.849549,"eighty":-12.989283,"marketCap":14429788347},{"date":"2021-12-10","current":-13.678439,"twenty":-18.435344,"median":-16.791123,"eighty":-12.950721,"marketCap":15734175994},{"date":"2021-12-17","current":-13.900665,"twenty":-18.427924,"median":-16.72442,"eighty":-12.950721,"marketCap":15978748678},{"date":"2021-12-24","current":-12.068814,"twenty":-18.41961,"median":-16.57278,"eighty":-12.854432,"marketCap":13886293494},{"date":"2021-12-31","current":-10.392945,"twenty":-18.411685,"median":-16.313069,"eighty":-12.599684,"marketCap":11984061508},{"date":"2022-01-07","current":-10.408899,"twenty":-11.114507,"median":-10.603378,"eighty":-10.458171,"marketCap":11956886766},{"date":"2022-01-14","current":-10.645935,"twenty":-11.136014,"median":-10.825867,"eighty":-10.516719,"marketCap":12255808935},{"date":"2022-01-21","current":-11.846284,"twenty":-11.23402,"median":-10.950741,"eighty":-10.575568,"marketCap":13668895552},{"date":"2022-01-28","current":-10.719633,"twenty":-11.23402,"median":-10.92037,"eighty":-10.575568,"marketCap":12337333163},{"date":"2022-02-04","current":-10.961121,"twenty":-11.226983,"median":-10.955931,"eighty":-10.603378,"marketCap":12609080589},{"date":"2022-02-11","current":-11.151206,"twenty":-11.195149,"median":-10.961121,"eighty":-10.645935,"marketCap":12853653273},{"date":"2022-02-18","current":-10.838643,"twenty":-11.151206,"median":-10.933229,"eighty":-10.645935,"marketCap":12554731104},{"date":"2022-02-25","current":-10.531157,"twenty":-11.149804,"median":-10.879658,"eighty":-10.555938,"marketCap":12228634192},{"date":"2022-03-04","current":-10.223007,"twenty":-11.133246,"median":-10.844907,"eighty":-10.526339,"marketCap":11875362538},{"date":"2022-03-11","current":-8.809298,"twenty":-11.096591,"median":-10.772075,"eighty":-10.439214,"marketCap":10217703236},{"date":"2022-03-18","current":-8.973146,"twenty":-11.067899,"median":-10.693082,"eighty":-10.247041,"marketCap":10859027162},{"date":"2022-03-25","current":-9.408384,"twenty":-11.060746,"median":-10.645935,"eighty":-9.613254,"marketCap":11386217170},{"date":"2022-04-01","current":-8.944167,"twenty":-11.060302,"median":-10.579658,"eighty":-9.555081,"marketCap":10837287368},{"date":"2022-04-08","current":-9.101703,"twenty":-11.051173,"median":-10.532504,"eighty":-9.487781,"marketCap":11032945515},{"date":"2022-04-14","current":-8.829357,"twenty":-10.996229,"median":-10.520302,"eighty":-9.272441,"marketCap":10685108809},{"date":"2022-04-22","current":-8.439191,"twenty":-10.958109,"median":-10.475675,"eighty":-9.02764,"marketCap":10022045089},{"date":"2022-04-29","current":-9.033079,"twenty":-10.95245,"median":-10.408899,"eighty":-8.917879,"marketCap":10554670045},{"date":"2022-05-06","current":-7.41082,"twenty":-10.943736,"median":-10.392945,"eighty":-8.839536,"marketCap":8587218677},{"date":"2022-05-13","current":-7.364351,"twenty":-10.915716,"median":-10.223007,"eighty":-8.8007,"marketCap":8380690633},{"date":"2022-05-20","current":-7.968917,"twenty":-10.889999,"median":-9.98237,"eighty":-8.584099,"marketCap":9195932912},{"date":"2022-05-27","current":-7.542162,"twenty":-10.879658,"median":-9.877618,"eighty":-8.1017,"marketCap":8695917648},{"date":"2022-06-02","current":-7.839485,"twenty":-10.877545,"median":-9.647965,"eighty":-8.02985,"marketCap":9087233942},{"date":"2022-06-10","current":-8.770543,"twenty":-10.856339,"median":-9.531356,"eighty":-7.992051,"marketCap":10098134368},{"date":"2022-06-17","current":-8.742365,"twenty":-10.841148,"median":-9.348726,"eighty":-8.004315,"marketCap":10054654780},{"date":"2022-06-24","current":-8.23701,"twenty":-10.797885,"median":-9.166898,"eighty":-8.03147,"marketCap":9511159927},{"date":"2022-06-30","current":-8.326656,"twenty":-10.778323,"median":-9.060482,"eighty":-8.076162,"marketCap":9598119103},{"date":"2022-07-08","current":-8.497078,"twenty":-10.769546,"median":-8.973146,"eighty":-8.128672,"marketCap":9804647148},{"date":"2022-07-15","current":-8.681154,"twenty":-10.738924,"median":-8.890871,"eighty":-8.173221,"marketCap":9924216015},{"date":"2022-07-22","current":-8.295377,"twenty":-10.687772,"median":-8.843947,"eighty":-8.192495,"marketCap":9489420133},{"date":"2022-07-29","current":-7.886667,"twenty":-10.657029,"median":-8.819327,"eighty":-8.057303,"marketCap":9032884456},{"date":"2022-08-05","current":-7.136107,"twenty":-10.647839,"median":-8.783241,"eighty":-7.981108,"marketCap":8152422795},{"date":"2022-08-12","current":-7.088387,"twenty":-10.632543,"median":-8.711759,"eighty":-7.937979,"marketCap":8108943206},{"date":"2022-08-19","current":-8.891947,"twenty":-10.611473,"median":-8.651267,"eighty":-7.857437,"marketCap":8619828368},{"date":"2022-08-26","current":-9.878492,"twenty":-10.574914,"median":-8.756454,"eighty":-7.879762,"marketCap":9500290030},{"date":"2022-09-02","current":-9.641847,"twenty":-10.542686,"median":-8.8007,"eighty":-7.911799,"marketCap":9239412501},{"date":"2022-09-09","current":-8.585571,"twenty":-10.532235,"median":-8.776892,"eighty":-7.937979,"marketCap":8195902383},{"date":"2022-09-16","current":-8.205928,"twenty":-10.52923,"median":-8.711759,"eighty":-7.947262,"marketCap":7761106500},{"date":"2022-09-23","current":-7.850954,"twenty":-10.521509,"median":-8.645731,"eighty":-7.931397,"marketCap":7282831030},{"date":"2022-09-30","current":-6.666434,"twenty":-10.504967,"median":-8.625033,"eighty":-7.852429,"marketCap":6195841324},{"date":"2022-10-07","current":-6.701906,"twenty":-10.484881,"median":-8.591202,"eighty":-7.761108,"marketCap":6228451015},{"date":"2022-10-14","current":-7.35301,"twenty":-10.456108,"median":-8.583249,"eighty":-7.57143,"marketCap":6761075971},{"date":"2022-10-21","current":-7.951253,"twenty":-10.433151,"median":-8.545175,"eighty":-7.57143,"marketCap":7261091236},{"date":"2022-10-28","current":-6.796392,"twenty":-10.406061,"median":-8.508514,"eighty":-7.508003,"marketCap":6195841324},{"date":"2022-11-04","current":-6.754512,"twenty":-10.394357,"median":-8.473127,"eighty":-7.42644,"marketCap":6217581118},{"date":"2022-11-11","current":-6.097932,"twenty":-10.363764,"median":-8.469242,"eighty":-7.395321,"marketCap":5663216368},{"date":"2022-11-18","current":-6.753098,"twenty":-10.242234,"median":-8.45243,"eighty":-7.346759,"marketCap":6250190809},{"date":"2022-11-25","current":-6.736071,"twenty":-10.196623,"median":-8.439191,"eighty":-7.272097,"marketCap":6184971427},{"date":"2022-12-02","current":-7.773909,"twenty":-10.077914,"median":-8.37957,"eighty":-7.241589,"marketCap":7261091236},{"date":"2022-12-09","current":-8.002157,"twenty":-10.008085,"median":-8.295377,"eighty":-7.250791,"marketCap":7543708559},{"date":"2022-12-16","current":-7.535454,"twenty":-9.932205,"median":-8.278653,"eighty":-7.272097,"marketCap":7087172883},{"date":"2022-12-23","current":-7.51,"twenty":-9.898083,"median":-8.243002,"eighty":-7.316458,"marketCap":7065433089},{"date":"2022-12-30","current":-7.305703,"twenty":-9.88339,"median":-8.22445,"eighty":-7.296997,"marketCap":6956734118},{"date":"2023-01-06","current":-7.457393,"twenty":-9.877968,"median":-8.206319,"eighty":-7.311066,"marketCap":7174132059},{"date":"2023-01-13","current":-8.437239,"twenty":-9.858414,"median":-8.206709,"eighty":-7.320093,"marketCap":8271991662},{"date":"2023-01-20","current":-8.286606,"twenty":-9.834445,"median":-8.240006,"eighty":-7.327535,"marketCap":8054593721},{"date":"2023-01-27","current":-8.57561,"twenty":-9.827001,"median":-8.248307,"eighty":-7.330074,"marketCap":8337211045},{"date":"2023-02-03","current":-8.175491,"twenty":-9.75546,"median":-8.23701,"eighty":-7.341519,"marketCap":7989374339},{"date":"2023-02-10","current":-7.777299,"twenty":-9.742113,"median":-8.206319,"eighty":-7.345196,"marketCap":7554578456},{"date":"2023-02-17","current":-8.009725,"twenty":-9.697444,"median":-8.193537,"eighty":-7.35301,"marketCap":7706757015},{"date":"2023-02-24","current":-8.177484,"twenty":-9.647965,"median":-8.202583,"eighty":-7.359122,"marketCap":7771976397},{"date":"2023-03-03","current":-8.136456,"twenty":-9.641847,"median":-8.205928,"eighty":-7.362303,"marketCap":7782846294},{"date":"2023-03-10","current":-7.532958,"twenty":-7.936227,"median":-7.807589,"eighty":-7.663468,"marketCap":7152392265},{"date":"2023-03-17","current":-6.893844,"twenty":-29.280721,"median":-16.418697,"eighty":-8.337386,"marketCap":6608897412},{"date":"2023-03-24","current":-6.658655,"twenty":-29.278482,"median":-16.330752,"eighty":-8.295377,"marketCap":6456718853},{"date":"2023-03-31","current":-6.382321,"twenty":-29.265473,"median":-16.265645,"eighty":-8.279201,"marketCap":6141491838},{"date":"2023-04-06","current":-6.996826,"twenty":-29.261938,"median":-16.251298,"eighty":-8.277923,"marketCap":6728466280},{"date":"2023-04-14","current":-9.166043,"twenty":-29.244948,"median":-16.177122,"eighty":-8.278324,"marketCap":7282831030},{"date":"2023-04-21","current":-10.375279,"twenty":-29.156297,"median":-16.110434,"eighty":-8.280198,"marketCap":8239381971},{"date":"2023-04-28","current":-9.791172,"twenty":-28.966769,"median":-16.017528,"eighty":-8.284669,"marketCap":7717626912},{"date":"2023-05-05","current":-9.403412,"twenty":-28.879119,"median":-15.969405,"eighty":-8.286606,"marketCap":7424139691},{"date":"2023-05-12","current":-9.274529,"twenty":-28.852641,"median":-15.860307,"eighty":-8.292601,"marketCap":7271961133},{"date":"2023-05-19","current":-8.816242,"twenty":-28.781694,"median":-15.853497,"eighty":-8.295377,"marketCap":6815425456},{"date":"2023-05-25","current":-7.906691,"twenty":-28.683645,"median":-15.812226,"eighty":-8.286122,"marketCap":6087142353},{"date":"2023-06-02","current":-7.650251,"twenty":-28.635789,"median":-15.707766,"eighty":-8.27382,"marketCap":5869744412},{"date":"2023-06-09","current":-7.718055,"twenty":-28.62839,"median":-15.523719,"eighty":-8.241804,"marketCap":5913224000},{"date":"2023-06-16","current":-8.211383,"twenty":-28.539889,"median":-15.189066,"eighty":-8.211383,"marketCap":6261060706},{"date":"2023-06-23","current":-7.66872,"twenty":-28.479972,"median":-15.018009,"eighty":-8.206397,"marketCap":5815394927},{"date":"2023-06-30","current":-8.028021,"twenty":-28.434831,"median":-14.894025,"eighty":-8.185553,"marketCap":6032792868},{"date":"2023-07-07","current":-9.203166,"twenty":-28.42021,"median":-14.728988,"eighty":-8.185553,"marketCap":6902384633},{"date":"2023-07-14","current":-9.275907,"twenty":-28.374356,"median":-14.588335,"eighty":-8.192495,"marketCap":7054563191},{"date":"2023-07-21","current":-9.07511,"twenty":-28.325294,"median":-14.52296,"eighty":-8.195817,"marketCap":6869774941},{"date":"2023-07-28","current":-9.214207,"twenty":-28.276566,"median":-14.467488,"eighty":-8.201914,"marketCap":6967604015},{"date":"2023-08-04","current":-8.538775,"twenty":-28.107178,"median":-14.183362,"eighty":-8.20624,"marketCap":6467588750},{"date":"2023-08-11","current":-8.096561,"twenty":-27.877746,"median":-13.991007,"eighty":-8.191975,"marketCap":6098012250},{"date":"2023-08-18","current":-7.762464,"twenty":-27.830986,"median":-13.842305,"eighty":-8.175132,"marketCap":5804525030},{"date":"2023-08-25","current":-26.697795,"twenty":-27.784384,"median":-13.828395,"eighty":-8.158004,"marketCap":5837134721},{"date":"2023-09-01","current":-29.706597,"twenty":-28.107178,"median":-13.888892,"eighty":-8.170209,"marketCap":6521938236},{"date":"2023-09-08","current":-30.060486,"twenty":-28.420665,"median":-14.123754,"eighty":-8.173421,"marketCap":6521938236},{"date":"2023-09-15","current":-29.580626,"twenty":-28.629171,"median":-14.286381,"eighty":-8.175132,"marketCap":6467588750},{"date":"2023-09-22","current":-28.661921,"twenty":-28.647461,"median":-14.50559,"eighty":-8.176288,"marketCap":6239320912},{"date":"2023-09-29","current":-25.921048,"twenty":-28.629171,"median":-14.562003,"eighty":-8.182864,"marketCap":5652346471},{"date":"2023-10-06","current":-24.561986,"twenty":-28.613095,"median":-14.613721,"eighty":-8.191454,"marketCap":5353424302},{"date":"2023-10-13","current":-26.92125,"twenty":-28.546356,"median":-14.838741,"eighty":-8.194677,"marketCap":5858874515},{"date":"2023-10-20","current":-24.986856,"twenty":-28.505231,"median":-14.94306,"eighty":-8.200576,"marketCap":5429513581},{"date":"2023-10-27","current":-30.077169,"twenty":-28.55348,"median":-15.089723,"eighty":-8.205928,"marketCap":6532808133},{"date":"2023-11-03","current":-36.685816,"twenty":-28.661921,"median":-15.342423,"eighty":-8.206709,"marketCap":7989374339},{"date":"2023-11-10","current":-34.996098,"twenty":-28.781694,"median":-15.589929,"eighty":-8.211383,"marketCap":7619797839},{"date":"2023-11-17","current":139.007258,"twenty":-28.852641,"median":-15.556824,"eighty":-8.205928,"marketCap":8271991662},{"date":"2023-11-24","current":134.06759,"twenty":-28.781694,"median":-15.273067,"eighty":-8.177484,"marketCap":8043723824},{"date":"2023-12-01","current":123.410206,"twenty":-28.717643,"median":-15.018009,"eighty":-8.168722,"marketCap":7435009589},{"date":"2023-12-08","current":115.396674,"twenty":-28.676471,"median":-14.894025,"eighty":-8.136456,"marketCap":6924124427},{"date":"2023-12-15","current":112.572734,"twenty":-28.665909,"median":-14.728988,"eighty":-8.09843,"marketCap":6793685662},{"date":"2023-12-22","current":105.438504,"twenty":-28.661921,"median":-14.588335,"eighty":-8.0768,"marketCap":6358889780},{"date":"2023-12-29","current":124.600197,"twenty":-28.660248,"median":-14.542482,"eighty":-8.068487,"marketCap":7554578456},{"date":"2024-01-05","current":123.318541,"twenty":-28.647461,"median":-14.50559,"eighty":-8.040462,"marketCap":7424139691},{"date":"2024-01-12","current":129.388505,"twenty":-28.629171,"median":-14.286381,"eighty":-8.023906,"marketCap":7793716192},{"date":"2024-01-19","current":128.482233,"twenty":-28.598191,"median":-14.123754,"eighty":-8.004007,"marketCap":7728496809},{"date":"2024-01-26","current":127.895751,"twenty":-28.539232,"median":-13.888892,"eighty":-7.991336,"marketCap":7663277427},{"date":"2024-02-02","current":117.16038,"twenty":-28.492602,"median":-13.828395,"eighty":-7.968917,"marketCap":7011083603},{"date":"2024-02-09","current":116.043963,"twenty":-28.441459,"median":-13.741036,"eighty":-7.955731,"marketCap":6978473912},{"date":"2024-02-16","current":117.464597,"twenty":-28.421577,"median":-13.690402,"eighty":-7.951253,"marketCap":7065433089},{"date":"2024-02-23","current":117.542093,"twenty":-28.419298,"median":-13.613328,"eighty":-7.941856,"marketCap":7032823397},{"date":"2024-03-01","current":119.647539,"twenty":-28.344394,"median":-13.512101,"eighty":-7.915092,"marketCap":7163262162},{"date":"2024-03-08","current":126.672019,"twenty":-28.296644,"median":-13.425131,"eighty":-7.869405,"marketCap":7587188147},{"date":"2024-03-15","current":136.411129,"twenty":-28.24645,"median":-13.3476,"eighty":-7.842873,"marketCap":8163292692},{"date":"2024-03-22","current":12.973937,"twenty":-28.044189,"median":-13.218965,"eighty":-7.777299,"marketCap":7695887118},{"date":"2024-03-28","current":12.519209,"twenty":-28.009087,"median":-13.100065,"eighty":-7.772172,"marketCap":7402399897},{"date":"2024-04-05","current":13.37366,"twenty":-27.959496,"median":-13.038286,"eighty":-7.76525,"marketCap":7902415162},{"date":"2024-04-12","current":13.568308,"twenty":-27.877746,"median":-12.982107,"eighty":-7.733431,"marketCap":8021984030},{"date":"2024-04-19","current":13.635105,"twenty":-27.845088,"median":-12.954555,"eighty":-7.711179,"marketCap":8054593721},{"date":"2024-04-26","current":15.199524,"twenty":-27.834055,"median":-12.900046,"eighty":-7.66971,"marketCap":8967665074},{"date":"2024-05-03","current":15.30222,"twenty":-27.818775,"median":-12.756941,"eighty":-7.639641,"marketCap":9022014559},{"date":"2024-05-10","current":15.81776,"twenty":-27.795706,"median":-12.554537,"eighty":-7.60133,"marketCap":9348111471},{"date":"2024-05-17","current":16.559383,"twenty":-27.750416,"median":-12.52579,"eighty":-7.583293,"marketCap":9772037456},{"date":"2024-05-24","current":17.391151,"twenty":-27.748227,"median":-12.491199,"eighty":-7.548422,"marketCap":10239443030},{"date":"2024-05-31","current":17.373469,"twenty":-27.745702,"median":-12.342599,"eighty":-7.532958,"marketCap":10239443030},{"date":"2024-06-07","current":17.395042,"twenty":-27.698671,"median":-12.324879,"eighty":-7.475268,"marketCap":10239443030},{"date":"2024-06-14","current":17.410995,"twenty":-27.635676,"median":-12.220722,"eighty":-7.447557,"marketCap":10239443030},{"date":"2024-06-21","current":17.44752,"twenty":-27.579411,"median":-12.146878,"eighty":-7.429881,"marketCap":10239443030},{"date":"2024-06-28","current":21.169921,"twenty":-27.531991,"median":-12.107468,"eighty":-7.409463,"marketCap":12418857391},{"date":"2024-07-05","current":21.31352,"twenty":-27.509142,"median":-12.073098,"eighty":-7.391342,"marketCap":12500381619},{"date":"2024-07-12","current":20.958398,"twenty":-27.436,"median":-12.028963,"eighty":-7.356677,"marketCap":12310158420},{"date":"2024-07-19","current":20.772946,"twenty":-27.320477,"median":-12.010321,"eighty":-7.327535,"marketCap":12201459449},{"date":"2024-07-26","current":20.696058,"twenty":-27.195166,"median":-11.942483,"eighty":-7.298439,"marketCap":12201459449},{"date":"2024-08-02","current":20.846486,"twenty":-27.093894,"median":-11.893713,"eighty":-7.252794,"marketCap":12282983677},{"date":"2024-08-09","current":20.754283,"twenty":-27.015113,"median":-11.837535,"eighty":-7.211803,"marketCap":12310158420},{"date":"2024-08-16","current":21.066803,"twenty":-26.967771,"median":-11.806904,"eighty":-7.168418,"marketCap":12500381619},{"date":"2024-08-23","current":20.886927,"twenty":-26.955307,"median":-11.609004,"eighty":-7.109109,"marketCap":12446032133},{"date":"2024-08-30","current":16.43423,"twenty":-26.948522,"median":-11.548619,"eighty":-6.995646,"marketCap":12500381619},{"date":"2024-09-06","current":16.533448,"twenty":-26.930541,"median":-11.45821,"eighty":-6.871599,"marketCap":12581905846},{"date":"2024-09-13","current":16.576841,"twenty":-26.803138,"median":-11.259414,"eighty":-6.79064,"marketCap":12581905846},{"date":"2024-09-20","current":16.406845,"twenty":-26.713756,"median":-11.226983,"eighty":-6.778362,"marketCap":12527556361},{"date":"2024-09-27","current":16.0965,"twenty":-26.474991,"median":-11.12377,"eighty":-6.734055,"marketCap":12364507905},{"date":"2024-10-04","current":16.063334,"twenty":-26.12212,"median":-11.064322,"eighty":-6.695364,"marketCap":12282983677},{"date":"2024-10-10","current":16.275333,"twenty":-25.921214,"median":-11.005246,"eighty":-6.664268,"marketCap":12364507905},{"date":"2024-10-18","current":16.144897,"twenty":-25.637712,"median":-10.902857,"eighty":-6.619301,"marketCap":12201459449},{"date":"2024-10-25","current":15.534605,"twenty":-25.112408,"median":-10.861622,"eighty":-6.595078,"marketCap":11739488824},{"date":"2024-11-01","current":15.739753,"twenty":-24.881781,"median":-10.769967,"eighty":-6.445564,"marketCap":11902537280},{"date":"2024-11-08","current":15.16169,"twenty":-24.562552,"median":-10.648314,"eighty":-6.336141,"marketCap":11413391913},{"date":"2024-11-15","current":14.703704,"twenty":-23.751057,"median":-10.532504,"eighty":12.609275,"marketCap":10951421287},{"date":"2024-11-22","current":14.783679,"twenty":-23.53783,"median":-10.449772,"eighty":13.062987,"marketCap":11005770773},{"date":"2024-11-29","current":15.706785,"twenty":-22.999838,"median":-10.31116,"eighty":13.490644,"marketCap":11685139339},{"date":"2024-12-06","current":16.219845,"twenty":-22.435947,"median":-10.035329,"eighty":13.731242,"marketCap":12038410993},{"date":"2024-12-13","current":16.288608,"twenty":-22.216491,"median":-9.890736,"eighty":14.555832,"marketCap":12065585736},{"date":"2024-12-20","current":17.613984,"twenty":-22.004449,"median":-9.806112,"eighty":14.82169,"marketCap":12989526986},{"date":"2024-12-27","current":17.627659,"twenty":-21.549335,"median":-9.748786,"eighty":14.920514,"marketCap":12989526986},{"date":"2025-01-03","current":17.426208,"twenty":-21.059501,"median":-9.644906,"eighty":15.101644,"marketCap":12853653273},{"date":"2025-01-10","current":17.15965,"twenty":-20.607327,"median":-9.566598,"eighty":15.217942,"marketCap":12609080589},{"date":"2025-01-17","current":14.05661,"twenty":-20.35213,"median":-9.486199,"eighty":15.260472,"marketCap":10337272104},{"date":"2025-01-24","current":11.824511,"twenty":-20.071108,"median":-9.37996,"eighty":15.260472,"marketCap":8750267133},{"date":"2025-01-28","current":12.245071,"twenty":-20.059273,"median":-9.37213,"eighty":15.246556,"marketCap":9108973736},{"date":"2025-02-07","current":14.732138,"twenty":-19.881739,"median":-9.29934,"eighty":15.274388,"marketCap":10897071802},{"date":"2025-02-14","current":15.503935,"twenty":-19.716064,"median":-9.259788,"eighty":15.394257,"marketCap":11440566655},{"date":"2025-02-21","current":15.602496,"twenty":-19.58997,"median":-9.203166,"eighty":15.430255,"marketCap":11576440368},{"date":"2025-02-28","current":20.173929,"twenty":-19.487135,"median":-9.138682,"eighty":15.600316,"marketCap":14918933714},{"date":"2025-03-07","current":22.691836,"twenty":-19.370014,"median":-9.081498,"eighty":15.678831,"marketCap":16848340443},{"date":"2025-03-14","current":22.646997,"twenty":-19.065782,"median":-8.992114,"eighty":15.77216,"marketCap":16821165700},{"date":"2025-03-21","current":22.326485,"twenty":-18.982567,"median":-8.937842,"eighty":15.869892,"marketCap":16576593016},{"date":"2025-03-28","current":21.446687,"twenty":-18.934089,"median":-8.881066,"eighty":15.958854,"marketCap":18832096656},{"date":"2025-04-03","current":20.496847,"twenty":-18.839523,"median":-8.833895,"eighty":16.064644,"marketCap":17962504891},{"date":"2025-04-11","current":17.855677,"twenty":-18.683014,"median":-8.776892,"eighty":16.101901,"marketCap":15543952795},{"date":"2025-04-17","current":21.145085,"twenty":-18.601961,"median":-8.681154,"eighty":16.211906,"marketCap":18451650259},{"date":"2025-04-25","current":23.553782,"twenty":-18.443201,"median":-8.6186,"eighty":16.246671,"marketCap":20571280186},{"date":"2025-05-02","current":25.056257,"twenty":-18.421123,"median":-8.595918,"eighty":16.285953,"marketCap":21930017318},{"date":"2025-05-09","current":21.736701,"twenty":-18.357986,"median":-8.578328,"eighty":16.307243,"marketCap":19158193568},{"date":"2025-05-16","current":24.221218,"twenty":-18.226089,"median":-8.538775,"eighty":16.352589,"marketCap":21522396178},{"date":"2025-05-23","current":25.67354,"twenty":-18.094256,"median":-8.474772,"eighty":16.43423,"marketCap":22881133311},{"date":"2025-05-30","current":28.32371,"twenty":-18.042007,"median":-8.459142,"eighty":16.529212,"marketCap":25354034892},{"date":"2025-06-06","current":27.615744,"twenty":-18.001357,"median":-8.448171,"eighty":16.543914,"marketCap":24783365296},{"date":"2025-06-13","current":28.93664,"twenty":-17.933569,"median":-8.429191,"eighty":16.59113,"marketCap":25979053973},{"date":"2025-06-20","current":29.114781,"twenty":-17.88088,"median":-8.326656,"eighty":16.663735,"marketCap":26087752944},{"date":"2025-06-27","current":30.394421,"twenty":-17.812992,"median":-8.289604,"eighty":17.360329,"marketCap":27310616363},{"date":"2025-07-04","current":33.810314,"twenty":-17.801509,"median":-8.277953,"eighty":17.373683,"marketCap":30381362282},{"date":"2025-07-11","current":31.664802,"twenty":-17.567437,"median":-8.248047,"eighty":17.392581,"marketCap":28424780811},{"date":"2025-07-18","current":38.172983,"twenty":-17.446462,"median":-8.211383,"eighty":17.398695,"marketCap":34240175739},{"date":"2025-07-25","current":37.581872,"twenty":-17.327692,"median":-8.192235,"eighty":17.415819,"marketCap":33832554599},{"date":"2025-08-01","current":40.093578,"twenty":-17.167788,"median":-8.170581,"eighty":17.4341,"marketCap":35870660298},{"date":"2025-08-08","current":44.992727,"twenty":-17.097162,"median":-8.121718,"eighty":17.480128,"marketCap":40354492835},{"date":"2025-08-15","current":50.734499,"twenty":-17.058582,"median":-8.093911,"eighty":17.621631,"marketCap":45436169710},{"date":"2025-08-22","current":50.833217,"twenty":-16.859598,"median":-8.068042,"eighty":18.705535,"marketCap":45381820225},{"date":"2025-08-29","current":46.979642,"twenty":-16.745455,"median":-8.037018,"eighty":20.138159,"marketCap":42338249048},{"date":"2025-09-05","current":49.410758,"twenty":-16.617085,"median":-8.00783,"eighty":20.53569,"marketCap":44485053718},{"date":"2025-09-12","current":47.905886,"twenty":-16.339663,"median":-7.991861,"eighty":20.742638,"marketCap":43207840813},{"date":"2025-09-19","current":46.794173,"twenty":-16.219396,"median":-7.96845,"eighty":20.789539,"marketCap":42175200592},{"date":"2025-09-26","current":43.258153,"twenty":-16.026591,"median":-7.951507,"eighty":20.858338,"marketCap":38887056732},{"date":"2025-10-03","current":44.331295,"twenty":-15.928376,"median":-7.944262,"eighty":20.881711,"marketCap":39946871695},{"date":"2025-10-10","current":43.248336,"twenty":-15.847839,"median":-7.921823,"eighty":20.912054,"marketCap":38914231474},{"date":"2025-10-17","current":43.312255,"twenty":-15.64105,"median":-7.867054,"eighty":20.962367,"marketCap":38941406217},{"date":"2025-10-24","current":42.027527,"twenty":-15.101997,"median":-7.840525,"eighty":21.030606,"marketCap":37800067026},{"date":"2025-10-31","current":42.145948,"twenty":-14.892482,"median":-7.774922,"eighty":21.062977,"marketCap":37963115482},{"date":"2025-11-07","current":36.889434,"twenty":-14.583069,"median":-7.760491,"eighty":21.163007,"marketCap":33207535518},{"date":"2025-11-14","current":40.397492,"twenty":-14.413417,"median":-7.721802,"eighty":21.238988,"marketCap":36468504636},{"date":"2025-11-21","current":38.428633,"twenty":-13.89831,"median":-7.676709,"eighty":21.585681,"marketCap":34674971621},{"date":"2025-11-28","current":41.440339,"twenty":-13.752396,"median":-7.636297,"eighty":22.072269,"marketCap":37528319599},{"date":"2025-12-05","current":40.470534,"twenty":-13.594758,"median":-7.584132,"eighty":22.535186,"marketCap":36713077320},{"date":"2025-12-12","current":38.751278,"twenty":-13.420541,"median":-7.553944,"eighty":23.01359,"marketCap":35218466474},{"date":"2025-12-19","current":37.317799,"twenty":-13.214352,"median":-7.521479,"eighty":23.576306,"marketCap":33995603055},{"date":"2025-12-24","current":35.744771,"twenty":-13.045166,"median":-7.478988,"eighty":23.970387,"marketCap":32664040665},{"date":"2026-01-02","current":34.716008,"twenty":-12.978171,"median":-7.44382,"eighty":24.465877,"marketCap":31848798385},{"date":"2026-01-09","current":39.593777,"twenty":-12.756941,"median":-7.425485,"eighty":25.67354,"marketCap":36414155151},{"date":"2026-01-16","current":40.201825,"twenty":-12.522546,"median":-7.394474,"eighty":26.927257,"marketCap":37093523717},{"date":"2026-01-23","current":34.580238,"twenty":-12.338702,"median":-7.35301,"eighty":28.32371,"marketCap":31875973128},{"date":"2026-01-30","current":33.630532,"twenty":-12.190645,"median":-7.317473,"eighty":29.131639,"marketCap":31142255076},{"date":"2026-02-06","current":37.350776,"twenty":-12.085096,"median":-7.259189,"eighty":29.964257,"marketCap":34674971621},{"date":"2026-02-13","current":40.950166,"twenty":-12.010551,"median":-7.227428,"eighty":30.740387,"marketCap":38234862908},{"date":"2026-02-20","current":42.116804,"twenty":-11.968357,"median":-7.203286,"eighty":31.56008,"marketCap":39267503129},{"date":"2026-02-27","current":38.661558,"twenty":-11.843211,"median":-7.124388,"eighty":32.960436,"marketCap":36441329893},{"date":"2026-03-06","current":40.109289,"twenty":-11.640497,"median":-6.995351,"eighty":33.58367,"marketCap":37501144857},{"date":"2026-03-13","current":38.594557,"twenty":-11.538107,"median":-6.848434,"eighty":33.84606,"marketCap":36251106695},{"date":"2026-03-20","current":37.26014,"twenty":-11.230502,"median":-6.780716,"eighty":34.607392,"marketCap":34865194819},{"date":"2026-03-27","current":41.61299,"twenty":-11.118085,"median":-6.740943,"eighty":35.408925,"marketCap":38968580960},{"date":"2026-04-02","current":44.244207,"twenty":-11.062177,"median":-6.706568,"eighty":36.129285,"marketCap":41631705739},{"date":"2026-04-10","current":47.774541,"twenty":-11.013975,"median":-6.665831,"eighty":36.356348,"marketCap":45300295997},{"date":"2026-04-16","current":47.582607,"twenty":-10.951311,"median":-6.649691,"eighty":36.992005,"marketCap":45137247541}],"updateTime":1776464555958},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02696\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2619150610","title":"关键研究启航，复星医药子公司复宏汉霖PD-L1 ADC HLX43在美国启动sqNSCLC II/III期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2619150610","media":"复星医药官微","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619150610?lang=zh_cn&edition=fundamental","pubTime":"2026-03-12 16:51","pubTimestamp":1773305506,"startTime":"0","endTime":"0","summary":"近日，复星医药子公司复宏汉霖宣布，公司已在美国启动一项针对创新抗PD-L1 抗体偶联药物HLX43用于晚期或转移性鳞状非小细胞肺癌的 II/III期国际多中心临床研究。目前，HLX43在NSCLC等实体瘤中展现出“高效、低毒”的初步临床疗效。目前，复宏汉霖正全力推进HLX43的临床开发进程，在全球入组超过700例患者。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312170748a4638d37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312170748a4638d37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000320223.HKD","BK1515","02696","BK1161","HK0000306701.USD","BK1593","02196","HK0000320264.USD","HK0000306685.HKD","HK0000165453.HKD","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618447971","title":"行业动态 | 全球研发 | 复星医药子公司复宏汉霖下一代TCE四特异性抗体HLX3901获国家药监局IND许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2618447971","media":"药学进展","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618447971?lang=zh_cn&edition=fundamental","pubTime":"2026-03-11 17:01","pubTimestamp":1773219674,"startTime":"0","endTime":"0","summary":"“点击蓝字 关注我们全球研发 | 复星医药子公司复宏汉霖下一代TCE四特异性抗体HLX3901获国家药监局IND许可PPS2026年3月9日，复星医药子公司复宏汉霖（2696.HK）宣布，基于自主研发的创新型T细胞衔接器（T-cell engager, TCE）平台开发的创新分子——HLX3901（DLL3 x DLL3 x CD3 x CD28 四特异性抗体）的新药临床试验（IND）申请已获得国","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311182128a460ff09&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311182128a460ff09&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02696","HK0000165453.HKD","HK0000306685.HKD","BK1593","BK1515","HK0000320264.USD","HK0000306701.USD","02196","HK0000320223.HKD","BK1191","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618924894","title":"每日卖空追踪 | 复宏汉霖 03月11日卖空量成交8700股，卖空比例为4.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618924894","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618924894?lang=zh_cn&edition=fundamental","pubTime":"2026-03-11 16:30","pubTimestamp":1773217833,"startTime":"0","endTime":"0","summary":"复宏汉霖北京时间03月11日，跌0.94%，卖空量成交8700股，较上一交易日减少93.98%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311163452a6b795d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311163452a6b795d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000320223.HKD","02696","HK0000306685.HKD","HK0000165453.HKD","HK0000320264.USD","BK1161","HK0000306701.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618692484","title":"复宏汉霖PD-L1 ADC启动全球II/III期关键研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2618692484","media":"医药魔方Info","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618692484?lang=zh_cn&edition=fundamental","pubTime":"2026-03-11 12:25","pubTimestamp":1773203156,"startTime":"0","endTime":"0","summary":"3月10日，美国临床试验收录网站显示，复宏汉霖启动了HLX43治疗鳞状非小细胞肺癌的II/III期研究。这是该药物启动的首项II/III期临床试验。HLX43是复宏汉霖基于宜联生物技术平台开发的一款PD-L1 ADC，其有效载荷为拓扑异构酶I抑制剂，DAR值为8。临床前研究显示，HLX43在PD-1/PD-L1单抗耐药的非小细胞肺癌、宫颈癌、食管鳞癌等多个瘤种中展现出治疗潜力，且耐受性良好。2025年11月，复宏汉霖公布了HLX43-FIH101及HLX43-NSCLC201两项临床研究的合并分析数据。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311122920a6b70a31&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311122920a6b70a31&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000306685.HKD","BK1161","HK0000320223.HKD","HK0000320264.USD","02696","HK0000165453.HKD","HK0000306701.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618120995","title":"同一日，康宁杰瑞、复宏汉霖等多家药企创新药迎来临床新进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2618120995","media":"动脉网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618120995?lang=zh_cn&edition=fundamental","pubTime":"2026-03-10 16:29","pubTimestamp":1773131340,"startTime":"0","endTime":"0","summary":"3月9日，康宁杰瑞、复宏汉霖、康方生物等多家药企创新药临床获新进展，覆盖多治疗领域，展现中国创新药研发实力。其中，康宁杰瑞登记了JSKN016的临床III期研究，预计招募364例三阴性乳腺癌患者，JSKN016是靶向TROP2和HER3双抗ADC，可发挥肿瘤杀伤作用；康方生物注射用AK150首次获批临床，用于治疗晚期实体瘤，依托AI制药与多抗技术平台研发，可同时调节先天和获得性免疫系统；科伦博泰与和铂医药共同申报的SKB575注射液获批临床，用于治疗特应性皮炎，是超长效靶向TSLP的双抗。此外，复宏汉霖DLL3xDLL3xCD3xCD28四特异性抗体药也有新进展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310164215a45e0020&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310164215a45e0020&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","HK0000306701.USD","HK0000165453.HKD","06978","HK0000320223.HKD","HK0000306685.HKD","BK1161","02696","HK0000320264.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618607592","title":"港股异动 | 复宏汉霖(02696)再涨超8% B7-H3唾液酸酶融合蛋白HLX316临床研究申请获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2618607592","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618607592?lang=zh_cn&edition=fundamental","pubTime":"2026-03-10 11:10","pubTimestamp":1773112220,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，复宏汉霖再涨超8%，截至发稿，涨5.08%，报69.3港元，成交额3373.1万港元。消息面上，3月9日，中国国家药监局药品审评中心官网公示显示，复宏汉霖1类新药注射用HLX316获批临床，拟开发治疗晚期/转移性实体瘤。公开资料显示，这是一款B7H3-唾液酸酶融合蛋白。截至本公告日期，于全球范围内尚无靶向B7-H3的唾液酸酶Fc融合蛋白获批上市。此外，2026年欧洲肺癌大会将于当地时间3月25日至28日在丹麦哥本哈根举行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1412005.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HK0000306701.USD","VXUS","HK0000320223.HKD","HK0000306685.HKD","BK4585","HK0000165453.HKD","BK1161","HK0000320264.USD","BK4588","02696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618995124","title":"复宏汉霖盘中异动 股价大涨5.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618995124","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618995124?lang=zh_cn&edition=fundamental","pubTime":"2026-03-10 09:37","pubTimestamp":1773106633,"startTime":"0","endTime":"0","summary":"2026年03月10日早盘09时37分，复宏汉霖股票出现波动，股价大幅拉升5.69%。截至发稿，该股报69.700港元/股，成交量4.55万股，换手率0.01%，振幅3.34%。资金方面，该股资金流入294.05万港元，流出12.985万港元。复宏汉霖股票所在的生物技术行业中，整体涨幅为1.93%。复宏汉霖公司简介：上海复宏汉霖生物技术股份有限公司是一家主要从事单克隆抗体产品的研发、生产及销售业务的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310093714a45ce75a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310093714a45ce75a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000320223.HKD","HK0000165453.HKD","HK0000306685.HKD","BK1161","HK0000306701.USD","02696","HK0000320264.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618567843","title":"潜在FIC，复宏汉霖B7-H3唾液酸酶融合蛋白HLX316临床研究申请中国获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2618567843","media":"复星","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618567843?lang=zh_cn&edition=fundamental","pubTime":"2026-03-09 18:46","pubTimestamp":1773053164,"startTime":"0","endTime":"0","summary":"内容来源：复宏汉霖2026年3月9日，复宏汉霖宣布，公司潜在同类首创靶向B7-H3的唾液酸酶融合蛋白HLX316的新药临床试验申请已获得国家药品监督管理局批准，拟用于晚期/转移性实体瘤的治疗研究。通过靶向表达B7-H3 的肿瘤细胞及其微环境发挥唾液酸酶活性，HLX316有潜力同时缓解蛋白和聚糖介导的免疫抑制，拓宽免疫治疗在实体瘤中的应用范围，突破现有治疗方案局限。HLX316的IND获批，是公司创新引擎持续加速运转的又一体现。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309205155a6b28c6b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309205155a6b28c6b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000165453.HKD","HK0000320223.HKD","HK0000320264.USD","HK0000306701.USD","BK1161","02696","HK0000306685.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618678129","title":"复星医药子公司复宏汉霖下一代TCE四特异性抗体HLX3901获国家药监局IND许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2618678129","media":"复星医药官微","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618678129?lang=zh_cn&edition=fundamental","pubTime":"2026-03-09 18:02","pubTimestamp":1773050574,"startTime":"0","endTime":"0","summary":"2026年3月9日，复星医药子公司复宏汉霖宣布，基于自主研发的创新型T细胞衔接器平台开发的创新分子——HLX3901的新药临床试验申请已获得国家药品监督管理局批准，拟用于晚期或转移性实体瘤的治疗，有望为临床难治性肿瘤，如小细胞肺癌等神经内分泌癌带来突破性的免疫治疗方案。同时，在食蟹猴的初步毒性研究中，HLX3901耐受性良好，显示出较宽的治疗窗口。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309181854a6b22299&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309181854a6b22299&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","HK0000306701.USD","02196","HK0000165453.HKD","02696","BK1515","BK1593","HK0000306685.HKD","HK0000320264.USD","HK0000320223.HKD","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618646918","title":"复宏汉霖(02696)：HLX3901注射液(DLL3xDLL3xCD3xCD28四特异性抗体)在晚期/转移性实体瘤患者中的临床试验申请获国家药品监督管理局批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2618646918","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618646918?lang=zh_cn&edition=fundamental","pubTime":"2026-03-09 16:31","pubTimestamp":1773045119,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复宏汉霖(02696)发布公告，近 日 ， HLX3901 注射液(DLL3xDLL3xCD3xCD28四特异性抗体)在晚期/转移性实体瘤患者中的1期临床试验申请(IND)获国家药品监督管理局(NMPA)批准。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1411601.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"复宏汉霖(02696)：HLX3901注射液(DLL3xDLL3xCD3xCD28四特异性抗体)在晚期/转移性实体瘤患者中的临床试验申请获国家药品监督管理局批准","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HK0000306685.HKD","HK0000320223.HKD","HK0000165453.HKD","HK0000320264.USD","HK0000306701.USD","BK1161","02696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618781176","title":"每日卖空追踪 | 复宏汉霖 03月09日卖空量成交14.8万股，卖空比例为7.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618781176","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618781176?lang=zh_cn&edition=fundamental","pubTime":"2026-03-09 16:30","pubTimestamp":1773045033,"startTime":"0","endTime":"0","summary":"复宏汉霖北京时间03月09日，跌4.42%，卖空量成交14.8万股，较上一交易日增加8.35%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309163447a6b1c86a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309163447a6b1c86a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000306701.USD","BK1161","02696","HK0000306685.HKD","HK0000320264.USD","HK0000320223.HKD","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618125678","title":"复宏汉霖盘中异动 早盘大幅跳水5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618125678","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618125678?lang=zh_cn&edition=fundamental","pubTime":"2026-03-09 09:31","pubTimestamp":1773019912,"startTime":"0","endTime":"0","summary":"2026年03月09日早盘09时31分，复宏汉霖股票出现波动，股价大幅下跌5.07%。截至发稿，该股报65.500港元/股，成交量1.64万股，换手率0.00%，振幅3.12%。机构评级方面，在所有3家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。复宏汉霖股票所在的生物技术行业中，整体跌幅为2.03%。复宏汉霖公司简介：上海复宏汉霖生物技术股份有限公司是一家主要从事单克隆抗体产品的研发、生产及销售业务的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309093152a6b0835b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309093152a6b0835b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","HK0000320264.USD","HK0000306701.USD","HK0000165453.HKD","02696","HK0000320223.HKD","HK0000306685.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617015815","title":"《股市简讯》中国复宏汉霖一度涨6.3%，国家药监局批准其抗癌药临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2617015815","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617015815?lang=zh_cn&edition=fundamental","pubTime":"2026-03-06 12:15","pubTimestamp":1772770546,"startTime":"0","endTime":"0","summary":"《股市简讯》中国复宏汉霖一度涨6.3%，国家药监局批准其抗癌药临床试验* 中国复星医药2196.HK600196.SS旗下研发生物类似药的复宏汉霖2696.HK周五早盘一度涨6.3%，早市收升5.1%。* 该公司此前公告称，自主研发的HLX97在晚期/转移性实体瘤患者中的1期临床试验申请获国家药品监督管理局批准。* 复宏汉霖今年迄今大涨19.3%，同期恒生指数.HSI上扬0.6%。* 恒⽣⽣物科技指数.HSBIO早盘收涨3.7%。（完）更多股市简讯请点选CN-CMN-HOT (发稿 徐凯文；审校 林高丽) ((kaiwen.xu@thomsonreuters.com))","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260306:nL4T3ZU0BB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000306685.HKD","BK1161","HK0000320264.USD","02696","HK0000320223.HKD","HK0000306701.USD","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617066845","title":"创新药板块强势 三生制药(01530)涨9.83% 机构指业绩兑现有望催化板块行情","url":"https://stock-news.laohu8.com/highlight/detail?id=2617066845","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617066845?lang=zh_cn&edition=fundamental","pubTime":"2026-03-06 10:41","pubTimestamp":1772764875,"startTime":"0","endTime":"0","summary":"金吾财讯 | 创新药板块强势，三生制药 涨9.83%，基石药业-B涨6.84%，荣昌生物涨6.31%，映恩生物-B涨5.98%，四环医药涨5.76%，恒瑞医药涨5.77%，君圣泰医药-B涨5.58%，康诺亚-B涨5.31%，复宏汉霖涨5.02%。交银国际表示，本周各公司业绩预告陆续发布，该机构建议持续关注财务表现超预期、盈利路径清晰的公司，其业绩兑现有望催化板块行情。","market":"hk","thumbnail":"https://static.szfiu.com/news/20241108/MGQ5MWNhYjgxMjA0ZDU3OGI4Y2EzYTk1OWIyNGM1NTg2NTUyNjEzMTk5Ng==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MGQ5MWNhYjgxMjA0ZDU3OGI4Y2EzYTk1OWIyNGM1NTg2NTUyNjEzMTk5Ng==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1976042","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","LU2543165471.USD","HK0000306685.HKD","02162","HK0000320223.HKD","LU1023057109.AUD","BK1574","BK1161","BK1600","06978","LU2328871848.SGD","09995","HK0000252152.HKD","LU0359202008.SGD","HK0000320264.USD","HK0000500386.USD","02696","LU0359201612.USD","LU1969619763.USD","09606","BK1583","HK0000165453.HKD","01530","159992","02616","BK1191","BK1515","HK0000252160.HKD","00460","LU0359201885.HKD","HK0000306701.USD","01276","02511","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617150523","title":"港股异动 | 复宏汉霖(02696)涨超5% 自研KAT6A/B小分子抑制剂HLX97获国家药监局IND许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2617150523","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617150523?lang=zh_cn&edition=fundamental","pubTime":"2026-03-06 10:10","pubTimestamp":1772763011,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，复宏汉霖(02696)涨超5%，截至发稿，涨5.02%，报68港元，成交额1948.15万港元。消息面上，3月5日，复宏汉霖发布公告，近日，本公司自主研发的HLX97(KAT6A/B小分子抑制剂)(HLX97)在晚期/转移性实体瘤患者中的1期临床试验申请(IND)获国家药品监督管理局(NMPA)批准。HLX97是本公司自主研发的赖氨酸乙酰转移酶6A/B(KAT6A/B)小分子抑制剂，拟用于治疗晚期/转移性实体瘤。非临床研究显示， HLX97可抑制KAT6A/B的活性，具有良好的抗肿瘤效果和安全性特征。截至本公告日，于全球范围内尚无KAT6A/B小分子抑制剂获批上市。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1410802.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HK0000306685.HKD","02696","HK0000320223.HKD","BK4588","VXUS","BK4585","HK0000165453.HKD","BK1161","HK0000306701.USD","HK0000320264.USD","VT","IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617254829","title":"全球尚无同类产品：复宏汉霖HLX97临床试验获批 靶向晚期/转移性实体瘤","url":"https://stock-news.laohu8.com/highlight/detail?id=2617254829","media":"财中社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617254829?lang=zh_cn&edition=fundamental","pubTime":"2026-03-05 18:01","pubTimestamp":1772704905,"startTime":"0","endTime":"0","summary":"3月5日，复宏汉霖（02696）发布公告，公司自主研发的HLX97（KAT6A/B小分子抑制剂）在晚期/转移性实体瘤患者中的1期临床试验申请获得国家药品监督管理局批准。HLX97旨在治疗晚期/转移性实体瘤，具有良好的抗肿瘤效果和安全性特征。截至公告日，全球范围内尚无KAT6A/B小分子抑制剂获批上市。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603053663266538.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["HK0000306685.HKD","HK0000320223.HKD","HK0000165453.HKD","HK0000320264.USD","HK0000306701.USD","BK1161","02696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171280574","title":"复宏汉霖HLX97（Kat6a/B小分子抑制剂）临床试验申请获国家药监局批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1171280574","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171280574?lang=zh_cn&edition=fundamental","pubTime":"2026-03-05 17:32","pubTimestamp":1772703177,"startTime":"0","endTime":"0","summary":"上海复宏汉霖生物技术股份有限公司宣布，其自主研发的HLX97（一种针对Kat6a/B的小分子抑制剂）临床试验申请，已获得国家药品监督管理局（NMPA）的正式批准。\n此次获批标志着该创新药物将进入临床开发阶段，为公司肿瘤治疗领域的管线增添了重要进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000320223.HKD","BK1161","HK0000306685.HKD","HK0000320264.USD","02696","HK0000306701.USD","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617552647","title":"复宏汉霖党委书记、董事会秘书王燕：优化生物医药政策环境 激发产业内生动力","url":"https://stock-news.laohu8.com/highlight/detail?id=2617552647","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617552647?lang=zh_cn&edition=fundamental","pubTime":"2026-03-05 00:19","pubTimestamp":1772641186,"startTime":"0","endTime":"0","summary":"复宏汉霖党委书记、董事会秘书王燕：优化生物医药政策环境 激发产业内生动力","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603053662129111.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603053662129111.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["161726","HK0000320264.USD","02696","HK0000165453.HKD","BK4585","HK0000306701.USD","BK1161","399441","HK0000306685.HKD","HK0000320223.HKD","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189551758","title":"复宏汉霖（02696）2月股份变动月报表：H股转增182,645,856股","url":"https://stock-news.laohu8.com/highlight/detail?id=1189551758","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189551758?lang=zh_cn&edition=fundamental","pubTime":"2026-03-04 18:11","pubTimestamp":1772619108,"startTime":"0","endTime":"0","summary":"上海复宏汉霖生物技术股份有限公司于2026年3月4日发布截至2026年2月28日的股份变动月报表。报告显示，本月公司依法完成非上市股份向H股的转换，使H股股本大幅增加。，公司公告披露，H股（普通股）期初数量为163,428,541股，因将182,645,856股非上市股份转为H股后，期末达到346,074,397股；非上市股份则由380,066,312股减少至197,420,456股。整体注册股本由上月合计543,494,853股维持不变。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617506435","title":"复宏汉霖潜在 best-in-class 小分子新药首次获批临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2617506435","media":"丁香园 Insight 数据库","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617506435?lang=zh_cn&edition=fundamental","pubTime":"2026-03-04 18:01","pubTimestamp":1772618463,"startTime":"0","endTime":"0","summary":"3 月 4 日，CDE 官网显示，复宏汉霖HLX97 临床试验申请获得批准，用于治疗晚期/转移性实体瘤。这是第 3 款获批临床的国产 KAT6A/B 抑制剂。来源：CDE 官网HLX97 是一款新型、潜在同类最优的口服组蛋白乙酰转移酶抑制剂。KAT6A/B 是乳腺癌等实体瘤治疗中极具潜力的靶点，其异常与多种血液肿瘤和实体瘤的发生发展密切相关。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030419342297a805ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030419342297a805ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000320264.USD","HK0000306701.USD","HK0000320223.HKD","HK0000306685.HKD","HK0000165453.HKD","BK1161","02696"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}